Better Sooner More Convenient Primary Care - New Zealand Doctor

More documents

Recommendations

Info

Laboratory There is anecdotal evidence to suggest that GPs and primary care nurses are referring some patients that may be able to be safely managed within primary care without referral for investigations. While there has been relative stability in year on year cost for laboratory services, there is an overall (small) increase. Despite this, there is evidence to show that some laboratory procedures and tests are duplicated unnecessarily leading us to believe that further efficiency can be gained. . Annual variance in laboratory costs – total DHB Year Laboratory $ Increase (decrease) for year % increase (decrease) for year 2005/2006 $1,148m - - 2006/2007 $1.336m $218k 19% 2007/2008 $1.186m ($150k) (11.2%) 2008/2009 $1.193m $130k 10.9% Change over 3 yrs $45k 3.9% Annual variance in laboratory costs – PHO only (from PPP) Year Laboratory $ Increase (decrease) for year % increase (decrease) for year 2005/2006 $678k 2006/2007 $680k $2k 0.3% 2007/2008 $732k $52k 7.7% 2008/2009 $650k ($82k) (11.2%) On the basis of preliminary investigations it is believed that there are opportunities for process improvement through the streamlining of referral systems, achieving a reduction in the type and quality of referral procedures and avoiding unnecessary or wasted expenditure on repeat laboratory testing. PHO Performance programme data on the West Coast PHO share of the national expenditure using a needs-based population formula, based on the enrolled population, for the period ending 30 September 2010, was significantly lower than the national average at 46.76 (performance target
them by technical errors or lack of detail in prescription details being brought to them by patients. PHO Performance programme data on the West Coast PHO share of the national expenditure using a needs-based population formula, based on the enrolled population, for the period ending 30 September 2010, was 83.57 for pharms (performance target
Page 1 and 2:
Business Case Better, Sooner, More
Page 3 and 4:
1 Caveats/status This business case
Page 5 and 6:
Current situation By three years Wa
Page 7 and 8:
staffed on a capacity model - in wh
Page 9 and 10:
support from DHBs, specialist clini
Page 11 and 12:
10.4 Key milestones................
Page 13 and 14:
Annual government health funding pe
Page 15 and 16:
Ambulatory Sensitive Hospitalisatio
Page 17 and 18:
The base populations of the three d
Page 19 and 20:
Māori/Pacific Not Māori/Pacific D
Page 21 and 22:
4.7 West Coast region service deliv
Page 23 and 24:
5 Future model of care 5.1 The desi
Page 25 and 26:
support them. Help with understandi
Page 27 and 28:
LEVERS VISION Better, sooner, more
Page 29 and 30:
providing the majority of care). Th
Page 31 and 32:
The Community Health System Deliver
Page 33 and 34:
To better integrate the support pro
Page 35 and 36:
5.5 Enablers A key aspect of this b
Page 37 and 38:
Two rounds of meetings with front l
Page 39 and 40:
While doctor-nurse substitution has
Page 41 and 42:
Nick Goodwin, Kings Fund 14 , in hi
Page 43 and 44:
Quality domains Each new initiative
Page 45 and 46:
Preventative Acute LTC management R
Page 47 and 48:
Preventative Acute LTC management R
Page 49 and 50:
The core services are provided or p
Page 51 and 52:
Total required FTEs for the Grey IF
Page 53 and 54:
7 Governance, Ownership & Managemen
Page 55 and 56:
Option D: PHO/DHB jointly owned Pri
Page 57 and 58:
The IFHS will need the ability to b
Page 59 and 60:
Of note, a large proportion of the
Page 61 and 62:
The DHB delegates decision making o
Page 63 and 64:
Limited integration of community se
Page 65 and 66:
10.4 Key milestones The table below
Page 67 and 68:
Expanded pharmacy roles Improving a
Page 69 and 70:
Devolved community based services w
Page 71 and 72:
Appendices Appendix One: Health Equ
Page 73 and 74:
ongoing GP shortage creating an env
Page 75 and 76:
10. What are the unintended consequ
Page 77 and 78:
It is common for people with an acu
Page 79 and 80:
Outcome measures Indicator Baseline
Page 81 and 82:
determine ratio of nurses and GPs t
Page 83 and 84:
C. Extended role for pharmacists:
Page 85 and 86:
11 Engagement Working group who dev
Page 87 and 88:
Appendix B: Acutely unwell adult pa
Page 89 and 90:
4 Objectives to implement nur
Page 91 and 92:
Review Buller after hours arrangeme
Page 93 and 94:
Year three Community education camp
Page 95 and 96:
13 Costs Budget considerations:
Page 97 and 98:
established. This group now oversee
Page 99 and 100: Output measures Tobacco control / s
Page 101 and 102: Improving immunisation coverage - h
Page 103 and 104: Year three Continued joint plan
Page 105 and 106: extending health promotion activiti
Page 107 and 108: Immunisation Coverage Funder Provid
Page 109 and 110: The Community Health System Deliver
Page 111 and 112: Clinical care Practice self managem
Page 113 and 114: and increases in the numbers of pat
Page 115 and 116: Ambulatory Sensitive Hospitalisatio
Page 117 and 118: % CVD on lipid lowering drugs, beta
Page 119 and 120: Health navigators/ kaiawhina: chan
Page 121 and 122: Committee‟s objectives 41 of prov
Page 123 and 124: - lack of consistency of care betwe
Page 125 and 126: qualifications and skills. Where ca
Page 127 and 128: 6 Deliverables / activities Impleme
Page 129 and 130: “With an aging population and an
Page 131 and 132: Differences between revenue generat
Page 133 and 134: Appendix Seven: Integration - Healt
Page 135 and 136: It is expected that HealthPathways
Page 137 and 138: Year two implement the process to
Page 139 and 140: Low uptake by primary and secondary
Page 141 and 142: Appendix Eight: Improved access to
Page 143 and 144: to easily access by telephone). Oth
Page 145 and 146: Year One - July 2010 to June 2011 T
Page 147 and 148: LECG 50 evaluated whether “the im
Page 149: Appendix Nine: Referred services 1.
Page 153 and 154: Identify patients that would benefi
Page 155 and 156: • Provision of patient specific m
Page 157 and 158: 12 Organisational accountabilities
Page 159 and 160: emain under the care and management
Page 161 and 162: Service user pathways in an optimal
Page 163 and 164: Model for shared care pathways deve
Page 165 and 166: Implementation plan: to June 30 Dev
Page 167 and 168: Year two Review progress, outcome m
Page 169 and 170: 10 Risk analysis Risk Probability I
Page 171 and 172: Appendix Eleven: Frail older people
Page 173 and 174: ehab and treatment programmes that
Page 175 and 176: Year one: Maintain and continue the
Page 177 and 178: Māori have a higher incidence of m
Page 179 and 180: 11 Organisational accountabilities
Page 181 and 182: There are often vacancies for allie
Page 183 and 184: 6 Deliverables / activities Program
Page 185 and 186: Professional development: Provide
Page 187 and 188: Mainstream arguments are concerned
Page 189 and 190: Appendix Thirteen: IFHCs - Faciliti
Page 191 and 192: A key possibility is that land at t
Page 193 and 194: This option is effectively a Greenf
Page 195 and 196: 7 Westland IFHC Facilities options
Page 197 and 198: Year two Substantive-IFHC in Greymo
Page 199 and 200: 12 Costs Capital costs Greymouth IF
Page 201 and 202:
utilize MedTech, but via their own
Page 203 and 204:
4 Objectives: To implement c
Page 205 and 206:
Security An individual‟s health i
Page 207 and 208:
8 Effect on inequalities The increa
Page 209:
Appendix Fifteen: Project advisory
show all

Better Sooner More Convenient Primary Care - New Zealand Doctor

Create successful ePaper yourself

Delete template?

Save as template?